Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review
International Journal of Molecular Sciences · 26.08.2023 · 24 (17) · 13262
DOI: 10.3390/ijms241713262 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.08.2023. Verfasst von Paul Kawak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemical and Biological Engineering Department, College of Engineering, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates. Hauptthemen laut MEDLINE: Transferrin, Glioblastoma. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dana Gas Endowed Chair for Chemical Engineering, American University of Sharjah Faculty Research Grants, Sheikh Hamdan Award for Medical Sciences, Friends of Cancer Patients (FoCP).
Abstract (Originalsprache)
Glioblastoma (GBM) is a highly aggressive brain tumor, and its treatment is further complicated by the high selectivity of the blood–brain barrier (BBB). The scientific community is urgently seeking innovative and effective therapeutic solutions. Liposomes are a promising new tool that has shown potential in addressing the limitations of chemotherapy, such as poor bioavailability and toxicity to healthy cells. However, passive targeting strategies based solely on the physicochemical properties of liposomes have proven ineffective due to a lack of tissue specificity. Accordingly, the upregulation of transferrin receptors (TfRs) in brain tissue has led to the development of TfR-targeted anticancer therapeutics. Currently, one of the most widely adopted methods for improving drug delivery in the treatment of GBM and other neurological disorders is the utilization of active targeting strategies that specifically target this receptor. In this review, we discuss the role of Tf-conjugated liposomes in GBM therapy and present some recent studies investigating the drug delivery efficiency of Tf-liposomes; in addition, we address some challenges currently facing this approach to treatment and present some potential improvement possibilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical and Biological Engineering Department, College of Engineering, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates.
- Materials Science and Engineering Program, College of Arts and Sciences, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates.
- Chemical Engineering Department, Brigham Young University, Provo, UT 84602, USA.
ORCID-Profile: Nour M Al Sawaftah, William G Pitt, Ghaleb A Husseini
Förderung
- Dana Gas Endowed Chair for Chemical Engineering, American University of Sharjah Faculty Research Grants
- Sheikh Hamdan Award for Medical Sciences
- Friends of Cancer Patients (FoCP)
Zitieren
APA
Kawak, P., Sawaftah, N. M. A., Pitt, W. G., & Husseini, G. A. (2023). Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review. International Journal of Molecular Sciences, 24(17), 13262. https://doi.org/10.3390/ijms241713262
Vancouver
Kawak P, Sawaftah NMA, Pitt WG, Husseini GA. Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review. International Journal of Molecular Sciences. 2023;24(17):13262. doi:10.3390/ijms241713262
BibTeX
@article{Kawak2023,
author = {Kawak, Paul and Sawaftah, Nour M Al and Pitt, William G and Husseini, Ghaleb A},
title = {Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {17},
pages = {13262},
doi = {10.3390/ijms241713262}
}
EUVIMED